
FDA Issues Class II Recall for 13,567 Bottles of Chlorthalidone Due to Dissolution Failures
The FDA has announced a Class II recall of 13,567 bottles of chlorthalidone 25mg tablets nationwide after the medication failed dissolution tests. This is the second recall for this specific drug and manufacturer in three months, affecting patients who rely on the medication for hypertension and fluid retention.













